Product Description
BTL EMSELLA uses HIFEM technology for PFM strengthening and reduction of UI. The device is consisted of a power generator and a circular coil mounted in the seat of the chair. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016513/)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Colombia
Approved Indications: None
Known Adverse Events: None
Company: William Beaumont Hospitals
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04873037 |
EmsellaOAB | N/A |
Recruiting |
Overactive Bladder |
2028-06-01 |
2025-12-12 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments |
|
NCT04133675 |
NCT04133675 | N/A |
Recruiting |
Urinary Incontinence, Stress|Enuresis |
2027-10-01 |
2024-11-08 |
||
NCT05370651 |
Emsella_EJD | N/A |
Recruiting |
Erectile Dysfunction|Pelvic Pain|Aging, Premature|Premature Ejaculation|Liver Failure |
2027-07-01 |
2025-12-12 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments |
|
NCT04031014 |
NCT04031014 | N/A |
Completed |
Overactive Bladder|Urinary Incontinence, Stress|Urinary Incontinence, Urge |
2025-07-01 |
2025-09-06 |
Primary Endpoints|Treatments|Trial Status |
|
NCT03877640 |
BTL EMSELLA | N/A |
Unknown status |
Urinary Incontinence, Urge|Urinary Incontinence, Stress |
2024-06-01 |
2025-11-01 |
Primary Endpoints|Treatments|Trial Status |
|
NCT04248491 |
EmsellaPain | N/A |
Terminated |
Pelvic Pain |
2023-01-18 |
2023-09-22 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date |
|
NCT04138602 |
NCT04138602 | N/A |
Withdrawn |
Fecal Incontinence |
2020-09-01 |
2020-09-10 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
Recent News Events
Date |
Type |
Title |
|---|